Jan Steyaert

Location

Region

flanders

Role

Founder

Company

TLDR

Jan Steyaert is the founder of Confo Therapeutics, a VIB-VUB spin-off developing GPCR-targeted drugs using conformational antibody technology.

Jan Steyaert is a professor at Vrije Universiteit Brussel and director of the Structural Biology Brussels lab at Vrije Universiteit Brussel, as well as Deputy-Director of the Structural Biology Research Center of Flanders Institute for Biotechnology. He founded Confo Therapeutics in 2015 as a spin-off from his lab at Vrije Universiteit Brussel and Flanders Institute for Biotechnology, based on the ConfoBody technology he developed for stabilizing GPCRs in pharmacologically relevant conformations. He is also a co-founder of Ablynx and Biotalys, and won the Jacob and Louise Gabbay Award in Biotechnology and Medicine in 2022.